DBV Technologies【DBV】銘柄情報

DBV Technologies (DBV) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.894

( 2.99% )

買値

2.85

売値

2.978

出来高

869,714

2.778 日の範囲 2.998

1.448 52 週間の範囲 4.50

時価総額

856.376M

前日終値

2.81

始値

2.80

時刻

3153

2.894

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

932,094 €

発行済株式数

295,914,379

配当利回り

PER

-4.21

1 株当たり利益 (EPS)

-0.76

歳入

5.74M

純利益

-167.45M

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanu... DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.dbv-technologies.com

本社

Châtillon, France

設立

2026

DBV Technologies is listed in the Healthcare sector of the ユーロネクスト with ticker DBV. The last closing price for DBV Technologies was 2.81 €. Over the last year, DBV Technologies shares have traded in a share price range of 1.448 € to 4.50 €.

DBV Technologies currently has 295,914,379 shares in issue. The market capitalisation of DBV Technologies is 856.38 € million. DBV Technologies has a price to earnings ratio (PE ratio) of -4.21.

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA...

DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans; la Société travaille en collaboration avec la FDA afin d'optimiser le processus d'examen en vue du dépôt du dossier

DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans; la Société travaille...

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

Châtillon, France, June 29, 2026 DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut...

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026

Châtillon, France, June 8, 2026 DBV Technologies to Present New Positive Data from VITESSE Study and Preview...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.074	2.62411347518	2.82	3.04	2.52	1060959	2.83002511	DE
4	-0.11	-3.66178428762	3.004	3.23	2.52	846560	2.85892398	DE
12	-0.688	-19.2071468453	3.582	3.89	2.52	1052389	3.23685255	DE
26	-0.431	-12.962406015	3.325	4.4	2.52	1158271	3.46619778	DE
52	1.248	75.8201701094	1.646	4.5	1.448	1109392	3.14967612	DE
156	-0.512	-15.0322959483	3.406	4.5	0.506	590962	2.29243442	DE
260	-6.778	-70.0785773366	9.672	10.52	0.506	459386	2.82081763	DE